Sm. Haffner et al., DISPROPORTIONATELY INCREASED PROINSULIN LEVELS ARE WITH THE INSULIN-RESISTANCE SYNDROME, The Journal of clinical endocrinology and metabolism, 79(6), 1994, pp. 1806-1810
Recent data suggest that proinsulin may be associated with increased c
ardiovascular risk factors in both diabetic and nondiabetic subjects.
We examined the relation of insulin, proinsulin, and the fasting proin
sulin/insulin ratio to a number of metabolic disorders believed to be
related to the insulin resistance syndrome (low high density lipoprote
in cholesterol and high triglyceride levels, hypertension, and impaire
d glucose tolerance). Proinsulin was measured by a RIA, and insulin wa
s measured by a Linco RIA that does not cross-react with proinsulin. T
he increased fasting proinsulin/insulin ratio was significantly associ
ated with hypertension, low high density lipoprotein cholesterol and h
igh triglyceride levels, and impaired glucose tolerance in 423 nondiab
etic subjects. The fasting proinsulin/insulin ratio increased signific
antly with the number of metabolic disorders (zero, 0.060; one, 0.086;
two, 0.098; three, 0.177; four, 0.182; P < 0.001). The increased proi
nsulin/insulin ratio was also associated with a greater number of meta
bolic disorders in diabetic subjects. Our results show that particular
ly nondiabetic individuals with the insulin resistance syndrome not on
ly have hyperinsulinemia as a marker of insulin resistance, but also s
how an increase in proinsulin relative to insulin, which may reflect r
elative beta-cell failure or malfunction.